iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Data Tools >
Price & News Alerts
Markets in 3D
More Tools >
My Image Gallery
Personal Finance Q&A
Cannabix Technologies Inc. (BLOZF)
Add BLOZF Price Alert
Search This Board:
11/22/2017 1:31:20 AM
- Board type:
- Posts Today:
Cannabix Technologies Inc.
formerly West Point Resources Inc.
And is a Vancouver, B.C. based company
Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.
Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
from the University of Florida
Rights for 10 Years after 1st Product sold
It Blocks Out Unwanted Molecules
Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost
Cannabix Technologies' Inc. common shares trade on
Canadian Securities Exchange
US OTC Pinksheets
European Frankfurt Exchange
US Patent Application
Canada Patent Application
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana. Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions. Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing
CSE:BLO Pinksheets: BLOZF
Issued and Outstanding
(as of Janurary 31, 2016)
Warrants Issued but not Exercised 5,634,325
Options Issued but not Exercised 8,961,300
IF a Patent is Issued
another 5M Shares
Fully Diluted w/Warrants, w/Options and w/Patent 5M Shares IF ISSUED
TOTAL DILUTED 105,690,101
Cannabix Corporate Video
Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc. Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development. Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.
Dr. Raj Attariwala, MD, PhD., Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL). Dr. Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver. He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products. Dr. Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.
Dr. Bruce Goldberger, PhD, Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida. Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.
Richard A. Yost Ph.D., Scientific Advisor
Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.
Jared Boock Ph.D,
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.
Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).
Rav Mlait, MBA – CEO, Director
Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.
Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.
Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge.
Andrew Davies, Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.
Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016). Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine.
BLOZF Detailed Quote
BLOZF News: Cannabis Infused Products Generating Mouth-watering Opportunities Across North American Legal Marijuana Industry
11/15/2017 12:27:58 PM
BLOZF News: Cannabix Technologies makes "50 B.C. Innovations to Watch List" with Marijuana Breathalyzer, Added to CSE25 Index
11/14/2017 08:15:00 AM
BLOZF News: Cannabix Technologies Files THC Based Ignition Interlock Patent Application and Provides Update on Marijuana Breathalyzer Dev...
11/07/2017 08:15:00 AM
BLOZF News: MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing
08/30/2017 10:29:33 PM
BLOZF News: PotNetwork Holdings, Inc Confirmed for MJAC 2017
08/28/2017 10:43:55 AM
Post New Msg
My Stocks (138)
Cannabix Technologies Develops Beta 3.0 Marijuana Breathalyzer and
08/01/17 09:16:11 PM
Cannabix is developing its FAIMS- (field asymmetric waveform
05/25/17 08:41:48 AM
In the middle of the journey, I came
11/22/17 01:31:20 AM
Good article! https://oracledispatch.com/2017/11/21/postive-signals-cannabix-te
11/21/17 11:25:04 PM
I'm guessing you should scroll back maybe a
11/21/17 09:25:01 PM
Sounds like you just went quiet from prolonged
11/21/17 08:32:04 PM
Makes no sense. This stock is golden. Most
11/21/17 08:19:32 PM
The only reason people spend so much time
11/21/17 08:12:48 PM
Why your gonna loose a lot of money
11/21/17 08:04:21 PM
Everybody ready for tomorrow? :)
11/21/17 07:52:54 PM
I find it funny those who complain about
11/21/17 06:22:05 PM
* You get what you pay for and
11/21/17 05:19:49 PM
Shhhhhhhheeeeeeeeeellllllllllppppp. This board is about to bash stock
11/21/17 04:38:10 PM
11/21/17 04:32:56 PM
Lol... some other guy told me they were
11/21/17 03:56:20 PM
Thank you to a number of forum members
11/21/17 03:54:52 PM
Cheap? Spelled that wrong over there and
11/21/17 03:54:19 PM
.70 by end of month
11/21/17 03:51:46 PM
Buy it up get it while it’s cheep.
11/21/17 02:27:37 PM
My sentiments exactly. BLOZF long!
11/21/17 02:00:41 PM
5x’s the volume on the Canadian side.
11/21/17 12:50:35 PM
Another beautiful day in Pennyland boys!
11/21/17 11:14:06 AM
Well said! $BLOZF
11/21/17 10:39:43 AM
Go Long. Playing a % of shares won't
11/21/17 10:38:53 AM
Law enforcement actually begged the Liberal government to
11/21/17 10:25:53 AM
11/21/17 10:25:47 AM
Looking great here folks!
11/21/17 10:08:46 AM
BLO.CN L2 gapping up 1.85 from 1.69z
11/21/17 09:23:41 AM
11/21/17 09:18:00 AM
Any indications on what this Canada announcement will be??
11/21/17 08:57:10 AM
Surprise if Canada does not ask for an
11/21/17 01:49:47 AM
BLOZF buy 1.33
11/21/17 12:16:18 AM
There may be something useful in this announcement
11/20/17 11:36:11 PM
What I meant is the $1.15 Units seem
11/20/17 11:01:32 PM
Thank you as always Shell Can you elaborate at
11/20/17 10:43:55 PM
First time posting, but been holding BLOZF for
11/20/17 09:28:58 PM
Read my mind Shell ......is quiet here
11/20/17 08:35:58 PM
Could see more squeeze panic tomorrow after today’s
11/20/17 08:15:59 PM
Doesn't close until December 7th
11/20/17 08:08:55 PM
Any comments on form 9 addendum?
11/20/17 07:59:24 PM
Still here - Just waiting - Looks as
11/20/17 07:59:17 PM
Solid day. Wondering what tomorrow brings??
11/20/17 06:28:13 PM
Awfully surprised so quiet here. SHELL !
11/20/17 06:11:57 PM
Hope to see a big squeeze soon!
11/20/17 05:12:21 PM
I’m excited for that Patent !!!! Show me
11/20/17 04:03:52 PM
$12 on announcement of approval for use in
11/20/17 03:35:28 PM
Love the prediction. How may have decided on
11/20/17 12:31:22 PM
11/20/17 12:24:16 PM
Good morning folks! $BLOZF
11/20/17 11:47:44 AM
What else might have been missed (and fun
11/20/17 11:22:11 AM
Yeah we are well aware as all of
11/20/17 11:05:47 AM
Today’s increased got you scared eh? Looking to
11/20/17 10:57:16 AM
Post New Msg
My Stocks (138)
© 2017 InvestorsHub.com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
Personal Finance Q&A
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App
iHub BlackBerry App